<DOC>
	<DOCNO>NCT00853645</DOCNO>
	<brief_summary>Primary objective evaluate safety performance implant S-ICD system . A maximum 10 subject enrol follow one month collect data safety , efficacy , performance implant S-ICD system . Additionally , patient comfort assess cosmetic outcome .</brief_summary>
	<brief_title>Initial Chronic Human Validation Study : Subcutaneous Implantable ( S-ICD ) System</brief_title>
	<detailed_description />
	<criteria>replacement exist transvenouse ICD system ACC/AHA/HRS Class I II indication ICD implantation Age &gt; = 18 year Appropriate preoperative ECG measure specially developed template Subjects unable unwilling provide inform consent Any condition precludes subject 's ability comply study requirement Remales pregnant lactate premenopausal woman unwilling use adequate birth control duration study Participation another investigational device trial time conduct SICD system trial without write consent sponsor . Patients serious medical condition life expectancy le one year . Patients document spontaneous frequently recur VT reliably terminate antitachycardia pacing Patients exist epicardial patch subcutaneous electrode leave thoracic quadrant Patients chronic renal failure , i.e . creatinine level &gt; 2.5 mg/dl unless prescribe drug therapy know increase creatinine level case value &lt; = 3mg/dl</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>